ApconiX Drug Safety Forum

Following the success of last year’s Drug Safety Forum, ApconiX has organised a Drug Safety Forum 2024, a free to attend, one day symposium on translational safety.

For this ambitious topic, we bring together a diverse array of industry toxicologists, patient safety/pharmacovigilance physicians and regulators to deliver a broad scope of critical and thought-provoking presentations. Speakers include friends and colleagues from AstraZeneca, Explic8, Lhasa Limited, ImmunONE and ApconiX.

The safety of healthy volunteers and patients in clinical trials and, ultimately, our drug products, rely on a complex interplay between many disciplines and functions of which nonclinical drug safety is only one. We call this multidisciplinary construct “Translational Safety”. It only works well when the scientific input is complemented by adequate strategies, operational setups, effective communication, and leadership.

We usually hear about Translational Safety when one or more components of this value chain break. Dr Steffen Ernst will give some noteworthy examples in his opening keynote address.

The meeting will be highly relevant for pharma and biotech industry, scientists, physicians, and regulators.

Find out more here https://www.apconix.com/drug-safety-forum-2024-a-patient-first-approach-to-transactional-safety-from-nonclinical-to-clinical/

Venue Name
Wellcome Collection
Venue Address
183 Euston Road
London
NW1 2BE